BioXcel Therapeutics, Inc. (BTAI)
1.63
-0.04
(-2.40%)
USD |
NASDAQ |
Mar 02, 16:00
1.63
0.00 (0.00%)
After-Hours: 20:00
BioXcel Therapeutics Accounts Payable (Quarterly) : 16.28M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 3.846M |
| Puma Biotechnology, Inc. | 5.056M |
| ACADIA Pharmaceuticals, Inc. | 10.90M |
| Alnylam Pharmaceuticals, Inc. | 115.72M |
| Savara, Inc. | 4.136M |